Cholangiocarcinoma (CCA) is a heterogeneous disease arising from a complex interaction
between host‐specific genetic background and multiple risk factors. Globally, CCA …

Cholangiocarcinoma is a disease entity comprising diverse epithelial tumours with features
of cholangiocyte differentiation: cholangiocarcinomas are categorized according to …

Hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) are the most
frequently occurring types of primary liver cancer and together are among the most common …

Background. Challenges in the diagnosis and classification of cholangiocarcinoma have
made it difficult to quantify the true incidence of this highly aggressive malignancy. Methods …

Biliary tract cancers, including intrahepatic, perihilar, and distal cholangiocarcinoma as well
as gallbladder cancer, are low-incidence malignancies in most high-income countries, but …

Cholangiocarcinoma (CCA) comprises a heterogeneous group of cancers with pathologic
features of biliary tract differentiation, and is presumed to arise from the intra-or extrahepatic …

Cholangiocarcinoma represents a diverse group of epithelial cancers united by late
diagnosis and poor outcomes. Specific diagnostic and therapeutic approaches are …

Primary liver cancer—including hepatocellular carcinoma (HCC) and intrahepatic
cholangiocarcinoma (ICC)—incidence is increasing and is an important source of cancer …

Importance Data on outcomes following surgical management of intrahepatic
cholangiocarcinoma (ICC) are limited. The incidence of ICC is increasing and it has a poor …

Background Cholangiocarcinoma (CCA) is clinically heterogeneous; intra and extrahepatic
CCA have diverse clinical presentations. Next generation sequencing (NGS) technology …